4 Einträge gefunden

1. Overall survival and adverse events after treatment with darolutamide vs. apalutamide vs. enzalutamide for high-risk non-metastatic castration-resistant prostate cancer: a systematic review and network meta-analysis

   1. Wenzel, Mike
   2. Nocera, Luigi
   3. Collà Ruvolo, Claudia
   4. Würnschimmel, Christoph
   5. Tian, Zhe
   6. Shariat, Shahrokh F
   7. Saad, Fred

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
2. Overall Survival After Systemic Treatment in High-volume Versus Low-volume Metastatic Hormone-sensitive Prostate Cancer: Systematic Review and Network Meta-analysis

   1. Wenzel, Mike
   2. Würnschimmel, Christoph
   3. Nocera, Luigi
   4. Collà Ruvolo, Claudia
   5. Tian, Zhe
   6. Shariat, Shahrokh F
   7. Saad, Fred

   2022 - Forschungsinformationssystem des UKE
3. Increasing rates of NCCN high and very high-risk prostate cancer versus number of prostate biopsy cores

   1. Wenzel, Mike
   2. Würnschimmel, Christoph
   3. Ruvolo, Claudia C
   4. Nocera, Luigi
   5. Tian, Zhe
   6. Saad, Fred
   7. Briganti, Alberto

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
4. External validation of the updated Briganti nomogram to predict lymph node invasion in prostate cancer patients undergoing extended lymph node dissection.

   1. Hansen, Jens
   2. Rink, Michael
   3. Bianchi, Marco
   4. Kluth, Luis A
   5. Tian, Zhe
   6. Ahyai, Sascha A
   7. Shariat, Shahrokh F

   2013 - Forschungsinformationssystem des UKE